Here are relevant reports on : OTC-drug
-
Antigen & Antibodies Market by Product (Antigens, ABs), Technique (ELISA, CLIA, IHS, IFA), Application (Diagnosis, Drug Discovery, Research), Healthcare Provider Facilities (ASCs & Clinics, Labs, Biotech& Pharma Companies) - Global Forecast to 2027
The global Antigen and Antibodies Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the advancing proteomics and genomics research, massive use of antigen and antibodies in the vaccine development, drug discovery, disease study and diagnosis.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Benign Prostatic Hyperplasia Treatment Market Size by Type [Drug (Alpha Blockers (Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA)], End User (Hospitals) & Region - Global Forecast to 2026
The size of global benign prostatic hyperplasia treatment market in terms of revenue was estimated to be worth USD 10.8 billion in 2021 and is poised to reach USD 14.1 billion by 2026, growing at a CAGR of 5.3% from 2021 to 2026. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023
The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Ear Health Market by Product (Ear Health Devices (Diagnostic Devices, Surgical Devices, Hearing Aids, Hearing Implants, CO2 Lasers), Ear Health Supplements, Ear Infection Drug Treatment), and Region - Global Forecast to 2026
The ear health market is expected to grow from USD 1.4 billion in 2021 to USD 1.9 billion by 2026, at a compound annual growth rate (CAGR) of 6.3% during the forecast period. The prominent players Sonova Holdings AG (Switzerland), Olympus Corp. (Japan), William Demant Holdings A/S (Denmark), Cochlear Limited (Australia), Stryker Corporation (US), Johnson & Johnson (US), Novartis (Switzerland), Karl Storz GMBH & Co. KG (Germany), Medtronic Plc (Ireland), Oscar Remedies Pvt Ltd. (India), and InnerScope Hearing Technologies (US).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Electronic Article Surveillance Market by Component (Tags, Antennas & Detachers), Technology, End User (Apparel & Fashion Accessories Stores, Supermarket & Mass Merchandise Stores, Drug & Health Product Stores), and Geography - Global Forecast to 2024
The electronic article surveillance (EAS) market is expected to grow from USD 981 million in 2019 to USD 1,173 million by 2024, at a CAGR of 3.6%. Modernizing retail sector and protection against inventory losses, shoplifting, and theft are the major driving factors for the market’s growth during the forecast period. Key players in the market include Checkpoint Systems (Canada), Johnson Controls (Ireland), Agon Systems (UK), ALL-TAG Corporation (US), Amersec (Czech Republic), TAG Company (UK), Ketec (US), WG Security Products (US), Softdel (US), Shenzhen Emeno Technology (China), Cross Point (The Netherland), Takachiho Koheki (Japan), Stanley Security (US), Shopguard Systems (Hungary), Dexilon Automation (Spain), Feltron Security Systems (UAE), and Sentry Custom Security (Canada).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market Size by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The size of global osteoarthritis therapeutics market in terms of revenue was estimated to be worth USD 7.3 billion in 2020 and is poised to reach USD 11.0 million by 2025, growing at a CAGR of 8.7% from 2020 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Nanotechnology Drug Delivery System Market by Type, End-User, Industry, Application and Region - Global Forecast to 2030
The market for drug delivery systems that use nanotechnology to improve the delivery and targeting of medicinal medicines to certain areas within the body is referred to as the "nanotechnology drug delivery system market." Drug delivery techniques based on nanotechnology solve problems with conventional approaches, such as low solubility, restricted bioavailability, and lack of specificity, by utilising nanoscale materials and structures.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Non-Alcoholic Steatohepatitis Treatment Market by Drug Class (Obeticholic Acid (OCA), Vitamin E and Pioglitazone, Distribution Channel (Hospitals, Pharmacies) – Global Forecast to 2027
The global non-alcoholic steatohepatitis (NASH) treatment market is projected to reach USD 15 billion by 2027 from USD 5 Billion in 2022, at a CAGR of ~25% during the forecast period
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Overactive Bladder Treatment Market Size by Drug type (Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) & Region - Global Forecast to 2027
The size of global overactive bladder treatment market in terms of revenue was estimated to be worth USD 3.5 billion in 2022 and is poised to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 7150
- TOC Available:
Records 41 to 50 of 50